Workshop to Explore Adult Immunization Strategies as a Pathway for Prevention and Wellness

PRAGUE, CZECH REPUBLIC – The rapid growth in aging populations across the globe leads to the need for more attention to the risks of disease and ways to keep us healthy and active as we age. In this context, the success of childhood vaccination programs and schedules – with regard to lives saved and costs averted – in both developed and developing countries should serve as models for both health and economic policy for adult immunization strategies. The Global Coalition on Aging (GCOA) will lead this workshop, which aims to address the role of adult immunization to advance wellness and build effective prevention strategies across the life course. Experts on the topics of aging, health policy, economics, and immunization will engage in a dialogue on the value proposition of adult immunization and the path forward.

WHO:
Michael Hodin, Executive Director, Global Coalition on Aging and Adjunct Senior Fellow, Council on Foreign Relations (Moderator)
Jane Barratt, Secretary General, International Federation on Ageing
Stephen McMahon, Governing Board Member, International Alliance of Patients’ Organizations (IAPO) and Chairman, Irish Patients Association
Prof. Roman Prymula, MD, PhD, Director, University Hospital, Hradec Kralove and Chairman of Central European Vaccine Advisory Board (CEVAG)
Michael Waldholz, Pulitzer Prize-winning journalist and author, former managing editor at Bloomberg News/ Businessweek and former bureau chief at the Wall Street Journal

WHAT:
“Adult Immunization: A Central Driver of Prevention and Wellness”

Concurrent Panel Discussion during 11th Global Conference on Ageing
International Federation on Ageing Conference
This initiative was made possible through a collaboration with Pfizer.

WHEN:  
Thursday 31 May, 11:30 – 13:00 CEST

LEARN MORE:
For the recap video, click here.
For Stephen McMahon’s reflections from the panel, read “The Prague Illumination.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Women, Work, Wellness, and That Aging Thing…

The OECD Forum’s virtual event Women at The Frontline of the Recovery will presciently focus attention among policymakers and the public stakeholders alike on the unique relationship between the age demographic mega-trend and the essential policies needed for OECD economies to emerge from the COVID-19 pandemic.

Headlines of the Future Podcast: Decoding Healthy Aging

How can advancements in science and medicine make it possible for individuals to enjoy greater health and activity in their later years? For health leaders and organizations such as the Global Coalition on Aging, ensuring individuals can truly shine in their "Golden Years" is a matter of revisiting education and communication strategies, advancing digital health technologies and expanding access to healthcare innovation.

Longer Lifespans Require Secure Financial Futures

As many as half of 5-year-olds in the United States can now expect to live to 100, a population that is projected to swell in the decades ahead. Longer lifespans don’t guarantee a financially secure later life, however. If anything, in the absence of significant planning, extreme longevity may make financial security harder to attain.

Financial Times Letter to the Editor

The call by Messrs Mario Draghi and Emmanuel Macron for a new growth strategy under France’s EU presidency should be guided by three principles aligned with their point about “demographic evolutions changing the structure of our societies” (Opinion, December 24).

Health Equity and Innovation Are at Risk for All of Us

The rapid development of COVID-19 vaccines illustrates what’s possible when federal policy fosters innovation with a real public-private partnership, especially for the health challenges facing America’s more than 54 million older adults. Yet, a number of drug-pricing policy proposals now jeopardize this very model, threatening to limit access to prescription drugs, compromise health equity and slow progress on urgently needed new treatments for age-related chronic conditions.